In this video from the DDN User Group at SC15, Kevin Behn from the HudsonAlpha Institute for Biotechnology presents: End to End Infrastructure Design for Large Scale Genomics.
“HudsonAlpha has generated major discoveries that impact disease diagnosis and treatment, created intellectual property, fostered biotechnology companies and expanded the number of biosciences-literate people, many of whom will take their place among the future life sciences workforce. Additionally, HudsonAlpha has created one of the world’s first end-to-end genomic medicine programs to diagnose rare disease. Genomic research, educational outreach, clinical genomics and economic development: each of these mission areas advances the quality of life.”
